Canafarma Outlines Hemp Product Development Strategy
This morning, Canafarma Hemp Products (CSE: CNFA) clarified to the market its continued development strategy for its hemp oil-based products while expanding upon the three verticals the firm currently operates within.
Presently, Canafarma operates within three verticals of hemp based consumer packaged goods. From here, it categorizes the multiple offerings it has for consumers, and where it intends to continue to focus product development, into an easy to understand format. Namely, these verticals are:
- Confectionary, which includes Canafarma’s Yooforic branded chewing gum and other soon to be released confectionary-based products.
- Beauty, which includes the recently announced acne skin care topical, as well as face creams and serums.
- Pain Relief, which will include topical creams not associated with beauty, as well as oils such as Yooforic branded tinctures.
Presently, Canafarma has seven different SKU’s within the confectionary segment associated with its flagship Yooforic chewing gum. The pain relief segment currently has Yooforic Joint & Muscle Cream, as well as four hemp-oil drop products. Beauty, as previously outlined, currently has one acne skin care topical in development for release in the second quarter.
Canafarma Hemp Products last traded at $0.98 on the CSE.
FULL DISCLOSURE: Canafarma Hemp Products Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Canafarma Hemp Products Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.